Updated COVID-19 Vaccines Reduce Hospitalization Risk in Adults With Autoimmune Rheumatic Conditions
Source Summary
An Arthritis & Rheumatology analysis of 60,980 U.S. adults with autoimmune rheumatic conditions who contracted COVID-19 between December 2020 and August 2024 found that those receiving booster or updated 2023–2024 COVID-19 vaccines had lower hospitalization rates than those with only initial vaccination or no vaccination. The study demonstrates protective benefit from updated vaccine formulations in this vulnerable population.
Why it matters
The findings provide evidence that updated COVID-19 vaccines offer meaningful protection against severe COVID-19 outcomes in immunocompromised adults with autoimmune rheumatic conditions.
